China plans to adopt a complete real-time monitor on narcotics
and first-grade psychopharmacy, sources with the Office of the
State Council Leading Group on Product Quality and Food Safety said
Friday.
By the end of this year, the real-time monitor will be placed on
the manufacturing, stocking, selling and storing of narcotics and
first-grade psychopharmacy nationwide.
Meanwhile, the authorities will carry out an inspection on the
process and prescriptions of large-volume injections, while
preparing for dispatching supervisors to manufacturers of
large-volume injections and special drugs.
Moreover, the authorities will continue monitoring domestic
pharmaceutical factories on the implementation of GMP (Good
Manufacturing Practices), an international regulation requiring
pharmaceutical and biotech firms to ensure their products meet
specifications for identity, strength, quality and purity.
(Xinhua News Agency September 3, 2007)